Back to User profile » Professor Yuan Li
Papers published by Professor Yuan Li:
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Testing for EGFR Mutations and ALK Rearrangements in Advanced Non-Small-Cell Lung Cancer: Considerations for Countries in Emerging Markets
Dalurzo ML, Avilés-Salas A, Soares FA, Hou Y, Li Y, Stroganova A, Öz B, Abdillah A, Wan H, Choi YL
OncoTargets and Therapy 2021, 14:4671-4692
Published Date: 1 September 2021
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
The prevalence and prognostic significance of KRAS mutation subtypes in lung adenocarcinomas from Chinese populations
Zheng DF, Wang R, Zhang Y, Pan YJ, Cheng XH, Cheng C, Zheng SB, Li H, Gong RX, Li Y, Shen XX, Sun YH, Chen HQ
OncoTargets and Therapy 2016, 9:833-843
Published Date: 22 February 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
SOX2 expression is associated with FGFR fusion genes and predicts favorable outcome in lung squamous cell carcinomas
Zheng S, Pan Y, Wang R, Li Y, Cheng C, Shen X, Li B, Zheng D, Sun Y, Chen H
OncoTargets and Therapy 2015, 8:3009-3016
Published Date: 19 October 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Comparison of clinical features, molecular alterations, and prognosis in morphological subgroups of lung invasive mucinous adenocarcinoma
![](cr_data/cache/submission_images/s70000/70984/70984 figure 1_200_200_90.jpg)
Cai D, Li H, Wang R, Li Y, Pan YJ, Hu HC, Zhang Y, Gong RX, Pan B, Sun YH, Chen HQ
OncoTargets and Therapy 2014, 7:2127-2132
Published Date: 18 November 2014
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Oncogenic mutations are associated with histological subtypes but do not have an independent prognostic value in lung adenocarcinoma
Hu H, Pan Y, Li Y, Wang L, Wang R, Zhang Y, Li H, Ye T, Zhang Y, Luo X, Shao L, Sun Z, Cai D, Xu J, Lu Q, Deng Y, Shen L, Ji H, Sun Y, Chen H
OncoTargets and Therapy 2014, 7:1423-1437
Published Date: 13 August 2014
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Protein expression of programmed death 1 ligand 1 and ligand 2 independently predict poor prognosis in surgically resected lung adenocarcinoma
Zhang Y, Wang L, Li Y, Pan Y, Wang R, Hu H, Li H, Luo X, Ye T, Sun Y, Chen H
OncoTargets and Therapy 2014, 7:567-573
Published Date: 12 April 2014
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Primary concomitant EGFR T790M mutation predicted worse prognosis in non-small cell lung cancer patients
Li H, Hu H, Wang R, Pan Y, Wang L, Li Y, Zhang Y, Ye T, Zhang Y, Li B, Shen L, Sun Y, Chen H
OncoTargets and Therapy 2014, 7:513-524
Published Date: 3 April 2014